An Arrayed Genome-wide Perturbation Screen Identifies the Ribonucleoprotein Hnrnpk As Rate-limiting for Prion Propagation
Overview
Authors
Affiliations
A defining characteristic of mammalian prions is their capacity for self-sustained propagation. Theoretical considerations and experimental evidence suggest that prion propagation is modulated by cell-autonomous and non-autonomous modifiers. Using a novel quantitative phospholipase protection assay (QUIPPER) for high-throughput prion measurements, we performed an arrayed genome-wide RNA interference (RNAi) screen aimed at detecting cellular host-factors that can modify prion propagation. We exposed prion-infected cells in high-density microplates to 35,364 ternary pools of 52,746 siRNAs targeting 17,582 genes representing the majority of the mouse protein-coding transcriptome. We identified 1,191 modulators of prion propagation. While 1,151 modified the expression of both the pathological prion protein, PrP , and its cellular counterpart, PrP , 40 genes selectively affected PrP . Of the latter 40 genes, 20 augmented prion production when suppressed. A prominent limiter of prion propagation was the heterogeneous nuclear ribonucleoprotein Hnrnpk. Psammaplysene A (PSA), which binds Hnrnpk, reduced prion levels in cultured cells and protected them from cytotoxicity. PSA also reduced prion levels in infected cerebellar organotypic slices and alleviated locomotor deficits in prion-infected Drosophila melanogaster expressing ovine PrP . Hence, genome-wide QUIPPER-based perturbations can discover actionable cellular pathways involved in prion propagation. Further, the unexpected identification of a prion-controlling ribonucleoprotein suggests a role for RNA in the generation of infectious prions.
Sinane M, Grunberger C, Gentile L, Moriou C, Chaker V, Coutrot P Mar Drugs. 2024; 22(10).
PMID: 39452864 PMC: 11509309. DOI: 10.3390/md22100456.
Heinzer D, Avar M, Pfammatter M, Moos R, Schwarz P, Buhmann M PLoS One. 2024; 19(6):e0304603.
PMID: 38870196 PMC: 11175539. DOI: 10.1371/journal.pone.0304603.
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD.
Hruska-Plochan M, Wiersma V, Betz K, Mallona I, Ronchi S, Maniecka Z Nature. 2024; 626(8001):1073-1083.
PMID: 38355792 PMC: 10901740. DOI: 10.1038/s41586-024-07042-7.
Avar M, Heinzer D, Thackray A, Liu Y, Hruska-Plochan M, Sellitto S EMBO J. 2022; 41(23):e112338.
PMID: 36254605 PMC: 9713719. DOI: 10.15252/embj.2022112338.